A preclinical trial of perventricular pulmonary valve implantation: Pericardial versus aortic porcine valves mounted on self-expandable stent
- PMID: 33090503
- DOI: 10.1111/aor.13845
A preclinical trial of perventricular pulmonary valve implantation: Pericardial versus aortic porcine valves mounted on self-expandable stent
Abstract
Perventricular pulmonary valve implantation (PPVI) of a xenograft valve can be a less invasive technique that avoids cardiopulmonary bypass in patients who require pulmonary valve replacement. We compared the hemodynamics, durability, and histologic changes between two different xenogenic valves (pericardial vs. aortic valve porcine xenografts) implanted into the pulmonary valve position using a PPVI technique and evaluated the safety and efficacy of PPVI as a preclinical study. In 18 sheep, pericardial (group porcine pericardial [PP], n = 9) or aortic valve (group porcine aortic valve [PAV], n = 9) xenogenic porcine valves manufactured as a stented valve were implanted using a PPVI technique. The porcine tissues were decellularized, alpha-galactosidase treated, fixed with glutaraldehyde after space-filler treatment, and detoxified to improve durability. Hemodynamic and immunohistochemical studies were performed after the implantation; radiologic and histologic studies were performed after a terminal procedure. All stented valves were positioned properly after the implantation, and echocardiography and cardiac catheterization demonstrated good hemodynamic state and function of the valves. All the anti-α-Gal IgM and IgG titers were below 0.3 optical density. Computed tomography of extracted valves demonstrated no significant differences in the degree of calcification between the two groups (P = .927). Microscopic findings revealed a minimal amount of calcification and no significant infiltration of macrophage or T-cell in both groups, regardless of the implantation duration. The PPVI is a feasible technique. Both stented valves made of PP and PAV showed no significant differences in hemodynamic profile, midterm durability, and degree of degenerative dystrophic calcification.
Keywords: animal study; congenital heart disease; pulmonary valve replacement; tissue engineering.
© 2020 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
Similar articles
-
Novel self-expandable, stent-based transcatheter pulmonic valve: a preclinical animal study.Int J Cardiol. 2014 Apr 15;173(1):74-9. doi: 10.1016/j.ijcard.2014.02.005. Epub 2014 Feb 20. Int J Cardiol. 2014. PMID: 24588954
-
Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.Eur J Cardiothorac Surg. 2015 Jul;48(1):104-13. doi: 10.1093/ejcts/ezu385. Epub 2014 Oct 14. Eur J Cardiothorac Surg. 2015. PMID: 25315752
-
Evaluation of transventricular placement of porcine small intestinal submucosa stent valves in the pulmonary position in juvenile sheep model.Interact Cardiovasc Thorac Surg. 2018 Aug 1;27(2):295-300. doi: 10.1093/icvts/ivy060. Interact Cardiovasc Thorac Surg. 2018. PMID: 29522111
-
Stentless aortic valve replacement: an update.Vasc Health Risk Manag. 2011;7:345-51. doi: 10.2147/VHRM.S11253. Epub 2011 Jun 2. Vasc Health Risk Manag. 2011. PMID: 21731886 Free PMC article. Review.
-
Aortic valve replacement with stentless porcine bioprostheses.J Card Surg. 1998 Sep-Oct;13(5):344-51. doi: 10.1111/j.1540-8191.1998.tb01096.x. J Card Surg. 1998. PMID: 10440649 Review.
References
REFERENCES
-
- Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-5.
-
- Luthra S, Westaby S, Ormerod O, Wilson N, Forfar C. Transventricular pulmonary valve implantation in corrected truncus arteriosus. Ann Thorac Surg. 2012;93:660-1.
-
- Vongpatanasin W, Hillis D, Lange R. Prosthetic heart valves. N Engl J Med. 1996;335:407-16.
-
- Gabbay S, Kadam P, Factor S, Cheung TK. Do heart valve bioprosthesis degenerate for metabolic or mechanical reasons? J Thorac Cardiovasc Surg. 1988;95:208-15.
-
- Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114:318-27.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous